Effective immediately, the following policy shall supersede prior Covid-19 protocol emergency policies for admitting and pre-admissions (including outpatient) to SJH: All surgical COVID-19 testing shall
Based on HHS and FDA recommendations, Bamlanivimab monotherapy should NOT be offered for COVID positive patients with mild to moderate disease. Due to variants, combination therapy of bamlanivimab and etesevimab should be offered. For now, St. Joseph’s will not offer Bamlanivimab monotherapy until we are able to obtain etesevimab.
Since we began distribution on Friday, December 18, nearly 2,000 frontline clinical and support employees have been vaccinated in what we’re all calling a “shot of hope.” We are pleased to open vaccination to all departments that were categorized as 1A, even if the department was originally scheduled for Week 2.
Click on Read More for this week’s schedule.
St. Joseph’s is anticipating arrival of the first doses of the Pfizer COVID-19 vaccine later this week. Because initial supplies of the vaccine provided to New Jersey hospitals will be limited, there will be a Phased Distribution process among staff, beginning with clinical and support team members who have Direct Patient and Public-Facing Interactions. With the number of vaccines we expect to receive, we believe we will have sufficient supply to vaccinate all in this category over the course of the first few weeks.
Beginning on Wednesday, November 18, all COVID-19 patients admitted to St. Joseph’s Health will be examined by one physician/LIP per day.
Please click Read More to view and download St. Joseph’s Emergency Oxygen Utilization Policy for COVID-19 patients. The policy was updated on November 15, 2020.
Click on Read More to view and download information.
Click on Read More to view and download information.
Click on Read More to view and download information.
